About [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone
[4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone (PubChem CID 130383991) has the molecular formula C33H40ClFN6O2
and a molecular weight of 607.17 g/mol. Its IUPAC name is [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone.
Molecular Properties
| Compound Name | [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone |
| PubChem CID | 130383991 |
| Molecular Formula | C33H40ClFN6O2 |
| Molecular Weight | 607.17 g/mol |
| Exact Mass | 606.29 |
| IUPAC Name | [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone |
| SMILES | CCCN1CN=C(N2CCN(C(=O)C3N(C)CCN3CCC)CC2)c2cc(Cl)c(-c3cc(O)cc4ccccc34)c(F)c21 |
| InChI | InChI=1S/C33H40ClFN6O2/c1-4-10-39-13-12-37(3)32(39)33(43)40-16-14-38(15-17-40)31-26-20-27(34)28(29(35)30(26)41(11-5-2)21-36-31)25-19-23(42)18-22-8-6-7-9-24(22)25/h6-9,18-20,32,42H,4-5,10-17,21H2,1-3H3 |
| InChIKey | YUYSWYLJNBXRDG-UHFFFAOYSA-N |
| XLogP | 5.07 |
| TPSA | 65.86 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 607.17 |
| LogP ≤ 5 | 5.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone?
The IUPAC name of [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone (CID 130383991) is [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone.
What is the SMILES notation for [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone?
The canonical SMILES for [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone is CCCN1CN=C(N2CCN(C(=O)C3N(C)CCN3CCC)CC2)c2cc(Cl)c(-c3cc(O)cc4ccccc34)c(F)c21.
What is the InChIKey of [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone?
The InChIKey is YUYSWYLJNBXRDG-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H40ClFN6O2/c1-4-10-39-13-12-37(3)32(39)33(43)40-16-14-38(15-17-40)31-26-20-27(34)28(29(35)30(26)41(11-5-2)21-36-31)25-19-23(42)18-22-8-6-7-9-24(22)25/h6-9,18-20,32,42H,4-5,10-17,21H2,1-3H3.
What are the key properties of [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone?
[4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone has a molecular weight of 607.17 g/mol, XLogP of 5.07, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[6-chloro-8-fluoro-7-(3-hydroxynaphthalen-1-yl)-1-propyl-2H-quinazolin-4-yl]piperazin-1-yl]-(1-methyl-3-propylimidazolidin-2-yl)methanone is sourced from PubChem (CID 130383991), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).